Inês Albuquerque - Laboratory Technician - FCT
Left Prudêncio lab in April 2014
Cláudia Sá e Cunha - Post-doctoral fellow - FCT
Cláudia's main research interest concerned the molecular analysis of the host components that interact with Plasmodium during a liver infection. Other projects involved the identification of new biomarkers to design diagnostic tools as well as RNAi screens to identify genes involved in a malaria liver infection, particularly those related to bile acid metabolism and nuclear receptors.
Left Prudêncio lab in September 2014
Miguel's Master's project concerned the characterization of a new malaria vaccine candidate against Plasmodium vivax using genetically modified rodent Plasmodium parasites. He presented and defended his thesis at Faculdade de Ciências de Lisboa in November 2014 and was graded 18/20.
Left Prudêncio lab in November 2014
Marija Markovic - Post-doctoral fellow - Bill & Melinda Gates Foundation
Marija was involved in a project towards developing a new whole-organism vaccine for malaria. Her specific goal was to find the most efficient way of producing high yields of P. berghei sporozoites in vitro, an important step in a further vaccine development. Thus, her research interest lied in understanding the parasite development in mosquito host and identification of various factors which lead to formation of infective sporozoites.
Left Prudêncio Lab in September 2015
One of the main goals of our lab is to develop malaria vaccine candidates using rodent parasite species as platforms for the delivery of human-infectious parasite antigens. Jorge was involved in the characterization of the cellular immune responses triggered by such transgenic liver stage parasites as part of our effort to obtain a safe and efficacious pre-erythrocytic intervention strategy against malaria. He further worked on the generation, characterisation and safety assessment of a new Plasmodium strain aiming at targeting the human disease-causing blood stage parasites. Finally, he was interested in identifying the cross-species parasite antigens that are recognised by immunoglobulins of animals immunised with these vaccine candidates.
Left Prudêncio Lab in October 2015
Cláudia Marques - Post-doctoral fellow - Bill & Melinda Gates Foundation
Cláudia was involved in an international project financed by Bill and Melinda Gates Foundation: “A new whole-organism vaccine against malaria”. My main tasks are to carry out assays towards the investigation of host-parasite interactions during in vivo Plasmodium infection of animal models. In order to evaluate the efficacy of immunization/vaccination, I am responsible to perform analysis of tissues and carry out assays for the measurement of cell subset-specific cellular immune responses.
Left Prudêncio Lab in June 2016